Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Monica Dandapani"'
Autor:
Sara Moufarrij, Monica Dandapani, Elisa Arthofer, Stephanie Gomez, Aneil Srivastava, Micael Lopez-Acevedo, Alejandro Villagra, Katherine B. Chiappinelli
Publikováno v:
Clinical Epigenetics, Vol 11, Iss 1, Pp 1-11 (2019)
Abstract Ovarian cancer is the deadliest gynecologic malignancy, with a 5-year survival rate of approximately 47%, a number that has remained constant over the past two decades. Early diagnosis improves survival, but unfortunately only 15% of ovarian
Externí odkaz:
https://doaj.org/article/3dab6fbd23804c20a94d7d1c87ebe7a2
Publikováno v:
Gynecologic Oncology Reports, Vol 14, Iss C, Pp 12-15 (2015)
A 71-year-old woman with suspected endometrial cancer underwent robotic-assisted hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymph node dissection, and infracolic omentectomy revealing a stage II uterine carcinosarcoma with
Externí odkaz:
https://doaj.org/article/fdc1ec8ff1504fc4a65ad714e442baf4
Autor:
Monica Dandapani, Brandon-Luke L. Seagle, Amer Abdullah, Bryce Hatfield, Robert Samuelson, Shohreh Shahabi
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2015 (2015)
Uterine sarcomas spread via lymphatic and hematogenous dissemination, direct extension, or transtubal transport. Distant metastasis often involves the lungs. Ovarian metastasis is uncommon. Here we present an unusual case of a large, high-grade uLMS
Externí odkaz:
https://doaj.org/article/861bee5727ba42e38355241f55f6a7f8
Publikováno v:
Surgical Innovation. 26:442-448
Background and Objectives. To describe a novel technique for a port-reducing laparoscopic hysterectomy. The 2-port laparoscopic hysterectomy (TPH) is performed through two 5-mm ports without the use of any multiport channels. We demonstrate outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73c61a1e83e0377bd9b4532e3f1de5c
https://doi.org/10.1177/1553350619827693
https://doi.org/10.1177/1553350619827693
Autor:
Wilberto Nieves-Neira, Anna E. Strohl, Shohreh Shahabi, Brandon Luke L. Seagle, Monica Dandapani
Publikováno v:
JCO Clinical Cancer Informatics. :1-15
Purpose We describe survival disparities among women with uterine, ovarian, or cervical cancer by cancer-specific mean annual hospital volume. Methods National Cancer Database 1998-2011 uterine (n = 441,863), ovarian (n = 223,017), and cervical (n =
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea93e151520396a9356860510584f46
https://doi.org/10.1200/cci.16.00053
https://doi.org/10.1200/cci.16.00053
Publikováno v:
Obstetrics and gynecology. 133(5)
Background When labor ensues in the setting of transabdominal cerclage, uterine rupture is a potential complication associated with significant morbidity and mortality for both mother and fetus. Case A woman with a transabdominal cerclage presented a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2248b780f25eb9a39036b2108ee7641
https://pubmed.ncbi.nlm.nih.gov/30969211
https://pubmed.ncbi.nlm.nih.gov/30969211
Autor:
Stephanie Gomez, Aneil Srivastava, Monica Dandapani, Katherine B. Chiappinelli, Elisa Arthofer, Micael Lopez-Acevedo, Sara Moufarrij, Alejandro Villagra
Publikováno v:
Clinical Epigenetics, Vol 11, Iss 1, Pp 1-11 (2019)
Clinical Epigenetics
Clinical Epigenetics
Ovarian cancer is the deadliest gynecologic malignancy, with a 5-year survival rate of approximately 47%, a number that has remained constant over the past two decades. Early diagnosis improves survival, but unfortunately only 15% of ovarian cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d3f70ab846d7c8da261a2a38110ba3
https://doi.org/10.1186/s13148-018-0602-0
https://doi.org/10.1186/s13148-018-0602-0
Autor:
Shohreh Shahabi, Kunle Odunsi, Brandon Luke L. Seagle, Kevin H. Eng, Monica Dandapani, Judy Y. Yeh
Publikováno v:
Oncotarget
The objective of this study was to determine if ovarian cancer patients with a TP53 mutation grouped by location of the mutation within the p53 protein structure exhibit differential survival outcomes. Data from patients with high grade serous ovaria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ce4fa7f723f11533247e6f83f92e79
https://doi.org/10.18632/oncotarget.4080
https://doi.org/10.18632/oncotarget.4080
Publikováno v:
International Journal of Gynecologic Cancer. 26:1078-1080
ObjectiveOvarian cancer is the gynecologic malignancy with the highest case-fatality rate due to the development of chemotherapy resistance. Predictors of chemotherapy response are needed to guide chemotherapy selection and improve survival for patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3889eec3c77006cb319c97ec5ae411d
https://doi.org/10.1097/igc.0000000000000726
https://doi.org/10.1097/igc.0000000000000726
Autor:
Kunle Odunsi, Judy Y. Yeh, Emily Schiller, Brandon Luke L. Seagle, Robert Samuelson, Monica Dandapani, Kevin H. Eng, Shohreh Shahabi
Publikováno v:
Scientific Reports
Tumor mRNA expression was used to discover genes associated with worse survival or no survival benefit after intraperitoneal (IP) chemotherapy. Data for high grade serous ovarian cancer patients treated with IP (n = 90) or IV-only (n = 398) chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c58aa203755dadc8490156d8e98b3278
http://europepmc.org/articles/PMC4756718
http://europepmc.org/articles/PMC4756718